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Differences in readmissions after open repair
versus endovascular aneurysm repair
Kevin Casey, MD,a Tina Hernandez-Boussard, PhD, MPH,b Matthew W. Mell, MD,b and
Jason T. Lee, MD,b San Diego and Stanford, Calif
Objective: Reintervention rates after repair of abdominal aortic aneurysm (AAA) are higher for endovascular repair
(EVAR) than for open repair, mostly due to treatment for endoleaks, whereas open surgical operations for bowel
obstruction and abdominal hernias are higher after open repair. However, readmission rates after EVAR or open repair
for nonoperative conditions and complications that do not require an intervention are not well documented. We sought
to determine reasons for all-cause readmissions within the first year after open repair and EVAR.
Methods: Patients who underwent elective AAA repair in California during a 6-year period were identified from theHealth
Care and Utilization Project State Inpatient Database. All patients who had a readmission in California <1 year of their
index procedure were included for evaluation. Readmission rates and primary and secondary diagnoses associated with
each readmission were analyzed and recorded.
Results: From 2003 to 2008, there were 15,736 operations for elective AAA repair, comprising 9356 EVARs (60%) and
6380 open repairs (40%). At 1 year postoperatively, the readmission rate was 52.1% after open repair and 55.4% after
EVAR (P .0003). The three most common principle diagnoses associated with readmission after any type of AAA repair
were failure to thrive, cardiac issues, and infection. When stratified by repair type, patients who underwent open repair
were more likely to be readmitted with primary diagnoses associated with failure to thrive, cardiac complications, and
infection compared with EVAR (all P< .001). Those who underwent EVARwere more likely, however, to be readmitted
with primary diagnoses of device-related complications (P  .05), cardiac complications, and infection.
Conclusions: Total readmission rates within 1 year after elective AAA repair are greater after EVAR than after open repair.
Reasons for readmission vary between the two cohorts but are related to the magnitude of open surgery after open repair,
device issues after EVAR, and the usual cardiac and infectious complications after either intervention. Systems-based
analysis of these causes of readmission can potentially improve patient expectations and care after elective aneurysm
repair. ( J Vasc Surg 2013;57:89-95.)
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wSince it was first described in 1991,1 endovascular
aneurysm repair (EVAR) has become the preferred method
of treatment for patients with abdominal aortic aneurysms
(AAA). Early studies have documented improvement in
operative mortality and initial complication rates after
EVAR.2 However, longer-term follow-up has suggested
that the early benefit of EVAR compared with open repair
might be lost several years after the procedure.3 The rea-
sons for the convergence of success rates are multifactorial
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http://dx.doi.org/10.1016/j.jvs.2012.07.005nd often related to the high number of secondary inter-
entions in the EVAR cohort, which are reported to be as
igh as 20% and have an increased morbidity and mortality
n patients requiring them.4 What remains challenging to
rack, however, and perhaps the reason for the scarcity of
iterature related to them, are nonoperative readmissions.
he importance of understanding all-cause readmissions,
articularly nonoperative causes, is highlighted in other
urgical procedures, where they increase the risk of future
omplications and subsequent mortality up to 11%.5
This study used a statewide database to evaluate the
ncidence of all postoperative readmissions 1 year after
lective AAA repair in California. The differences in read-
ission rates between EVAR and open repair were com-
ared as well as the actual causes and diagnoses of readmis-
ions between the two cohorts. Predictive demographic
actors associated with readmission 1 year of an elective
AA repair were examined to better understand systems-
ased issues surrounding readmission.
ETHODS
The State Inpatient Database (SID), developed as part
f the Healthcare Cost and Utilization Project sponsored
y the Agency for Healthcare Research and Quality, iden-
ified adults who underwent open repair or endovascular
epair of infrarenal AAA between 2003 and 2008. Patients
ere identified using International Classification of Dis-
ases, Ninth Revision (ICD-9) diagnosis codes for intact
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January 201390 Casey et alAAA (441.4, 441.9). For the purpose of this study, we
excluded patients identified with ICD-9 codes for ruptured
AAA (441.3, 441.5). Extremes of age were also considered
likely outliers, so inclusion criteria for this study was limited
to those aged between 40 and 90 years. Patients were
subdivided according to the ICD-9-Clinical Modification
codes of 38.44 for open repair and 39.71 for endovascular
repair. All patients at risk for 1-year readmission after
elective AAA repair were included in this study.
The SID contains a range of data collected from dis-
charge inpatient hospital records, including demographics,
ICD-9-Clinical Modification codes for primary and sec-
ondary diagnoses and procedures, admission source, length
of stay (LOS), discharge disposition, inpatient mortality,
and hospital characteristics. This database also allows for
identification of patient readmissions 1 full year in Cali-
fornia and attempts to capture patient data characteristics
from the readmission, including primary and secondary
diagnoses. Multiple readmissions from the same patient1
year counted toward the total number of readmissions for
that cohort.
For purposes of analysis, patient race was categorized as
white or nonwhite. Patients’ primary expected payer was
categorized as private, Medicare, Medicaid, or other. Co-
morbidity illnesses present on the index admission were
summarized using the Charlson Index, which considers
comorbid conditions as predictors of 10-year mortality. To
perform a longitudinal analysis, unique patient identifiers
were used to determine whether a single patient had a
subsequent hospital admission within the subsequent year.
Patient identifiers were not consistent across years and
therefore prevented analysis of patients across multiple
years.
Because multiple codes exist for all types of readmis-
sions and to create more broad categories of reasons for
readmission, we arbitrarily divided principle and secondary
diagnoses into systems-based problems and included sev-
eral different conditions under one larger medical diagnosis
(Table I). For instance, readmission diagnoses documented
as pneumonia organism not otherwise specified (486),
respiratory failure (51,881), obstructive chronic bronchitis
with active exacerbation (49,121), food/vomit pneumoni-
tis (5070), post-traumatic pulmonary insufficiency (5185),
and surgical complication: respiratory system (9972), were
combined to create a “pulmonary” classification for reason
for readmission.
We analyzed the 41 most frequent diagnoses and in-
cluded these in the follow-up evaluation. This captured
95% of the patients with readmissions. We excluded clear
outliers, those diagnoses that were clearly unrelated to a
patient’s aneurysm repair. These were infrequent and were
almost exclusively related to malignancies.
Statistical analysis. Statistical analyses were done with
SAS 9.2 (SAS Institute, Cary, NC) and Stata 11 (Stata-
Corp, College Station, Tex) software. Outcome variables
were compared with 2 analysis and t test, as appropriate.
Overall readmission rates were estimated using Kaplan-
Meier analysis. Comparison of these estimates by surgical mype was performed using the log-rank test. Modified Cox
roportional hazards modeling with adjustment for patient
nd hospital characteristics was used to adjust for patient
able I. Specific International Classification of Diseases-
inth Revision (ICD-9) diagnostic codes used to
ategorize readmission causes into groups of system-
ased criteria
ategory Code Indication
ailure to thrive V5789 Rehabilitation procedure NEC
V5873 Aftercare following
surgery/circulatory system
NEC
V571 Physical therapy NEC
V5849 Other postoperative aftercare
2765 Hypovolemia
27,651 Dehydration
ardiac 4280 Congestive heart failure
41,401 Coronary atherosclerosis native
vessel
41,071 Subendothelial infarct: initial
42,731 Atrial fibrillation
78,659 Chest pain NEC
42,781 Sinoatrial node dysfunction
78,650 Chest pain NOS
nfection 99,859 Other postoperative infection
389 Septicemia NOS
5990 Urinary tract infection NOS
3811 Staphylococcus aureus septicemia
VT/PE 4538 Venous thrombosis NEC
41,519 Other pulmonary embolism,
infarct
ulmonary 486 Pneumonia organism NOS
51,881 Respiratory failure
49,121 Obstructive chronic bronchitis
with active exacerbation
5070 Food/vomit pneumonitis
5185 Post-traumatic pulmonary
insufficiency
9972 Surgical complication: respiratory
system
astrointestinal 9974 Surgical complication:
gastrointestinal tract
5770 Acute pancreatitis
845 Clostridium difficile infection
mall bowel
obstruction
56,081 Intestinal adhesion with
obstruction
5609 Intestinal obstruction NOS
enal 5849 Acute renal failure NOS
erebrovascular
accident
43,491 Cerebral arterial occlusion NOS
with infarction
ound 55,321 Incisional hernia
99,813 Seroma procedure culture
99,831 Disruption of internal operative
wound
istal embolization 44,422 Lower extremity embolism
evice/aneurysm-
related
4414 Abdominal aortic aneurysm
99,674 Complication other vascular
device/graft
99,662 React-other vascular device/graft
9972 Surgical complication
perivascular system
VT, Deep venous thrombosis; NEC, not elsewhere classifiable; NOS, not
therwise specified; PE, pulmonary embolism.ix on readmission rates between the two surgical proce-
w
t
r
m
c
.
h
.
r
i
s
s
9
o
s
t
h
T
c
a
V
A
M
W
P
C
O
C
C
C
P
C
E
C
a
T
e
V
R
D
L
1
A
E
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 1 Casey et al 91dures. Patient characteristics included age, sex, race, insur-
ance status, obesity, complicated diabetes mellitus (DM),
complicated hypertension, peripheral vascular disease
(PVD), chronic obstructive pulmonary disease (COPD),
and end-stage renal disease.
RESULTS
Between 2003 and 2008, 17,749 AAAs were treated in
California. Of these, 1648 (9.2%) were ruptured AAAs and
were excluded from this analysis, which left 16,101 elective
AAA repairs. A further 365 patients were excluded for
various reasons, including extremes of age, incomplete or
omitted data, or inconsistent information from the subse-
quent follow-up period. The remaining 15,736 patients
underwent elective AAA repairs during the study period,
including EVAR in 9356 (59.5%) and open repair in 6380
(40.5%).
Analysis of the annual trends between EVAR and open
repair revealed an increase in the number of elective aneu-
rysm repairs performed from 2003 to 2008 (Fig 1). In
2003, 2475 elective AAA repairs were performed. By 2008,
this number had increased to 2701. A gradual but consis-
tent increase was noted in the number of EVARs per-
formed, from 1052 (in 2003) to 2023 (in 2008), and a
corresponding decrease, from 1423 to 678, in the number
of elective open repairs performed.
The baseline demographics between the two popula-
tions were heterogeneous (Table II). The mean age of
patients undergoing EVAR was 75 years compared with 72
years for open repair (P  .0001). The EVAR group also
had a larger percentage of men than the open repair group
(84.7% vs 75.6%; P  .0001). Patients who had an EVAR
were more likely to have complicated DM, whereas patients
having an open repair were more likely to have complicated
hypertension, COPD, and have private insurance com-
pared with Medicaid or Medicare. Patients undergoing an
open repair had a higher Charlson Index score and were
more likely to have a score 2 (55.52% vs 51.73% for
EVAR; P  .0001). The two groups did not differ with
Fig 1. During the course of the study period (2003 to 2008), the
number of total aneurysms repaired in California remained rela-
tively constant. Endovascular aneurysm repair (EVAR), however,
replaced open repair (OPEN) as the treatment method of choice.respect to race, obesity, PVD, or end-stage renal disease. TSurgical outcomes. The overall operative mortality
as 3.5% for all elective AAA repairs in California during
he study period, and was significantly higher after open
epair (6.7%) than after EVAR (1.4%; P  .0001). The
ean LOS at the surgical hospitalization was also signifi-
antly higher after open repair (10.5 vs 3.7 days; P 
0001). Early readmission rates (30 days of surgery) were
igher for the open surgery group (20.0% vs 17.4%; P 
0003). Patients were more likely to be discharged as a
outine disposition (ie, not to a nursing facility or rehabil-
tation center) after EVAR (84.3% vs 57.7%; P  .0001).
Readmissions. Patients were evaluated for readmis-
ions to an inpatient hospital 1 year of their index admis-
ion (Table III). In contrast to early readmission rates, the
0-day readmission rates were only slightly greater after
pen repair (31.3% vs 29.7%), but this did reach statistical
ignificance (P  .046). However, by 1 year postopera-
ively, the readmission rate after EVAR was significantly
igher than after open repair (55.4% vs 52.1%; P .0003).
able II. Comparison of baseline demographics and
omorbidities of all patients in California undergoing
neurysm repair from 2003 to 2008
ariable EVAR Open P
ge, years, mean (SD) 75.0 (8.3) 72.1 (9.0) .0001
ale sex, % 84.7 75.6 .0001
hite race, % 81.1 81.5 .4801
rivate insurance, % 15.3 20.8 .0001
harlson Index 2, % 51.7 55.5 .0001
besity, % 7.2 7.0 .5723
HF, % 9.8 14.1 .0001
omplicated DM, % 1.7 1.2 .01
omplicated HTN, % 9.0 10.9 .0001
eripheral vascular disease, % 98.8 98.5 .0420
OPD, % 29.2 37.7 .0001
nd-stage renal disease, % 8.6 9.1 .2320
HF, Congestive heart failure;DM, diabetes mellitus; EVAR, endovascular
neurysm repair; HTN, hypertension; SD, standard deviation.
able III. Readmission data of patients undergoing
ndovascular repair or open repair
ariable EVAR Open P
eadmission, %
30 days 17.4 20.0 .0003
90 days 29.7 31.3 .046
1 year 55.4 52.1 .0003
ays to readmission,
mean (SD)
83.2 (107.3) 57.1 (107.4) .0001
ength of stay at first
readmission,
mean (SD)
2.1 (4.2) 8.0 (11.3) .0001
-year risk-adjusted
mortality, %
2.44 7.79 .0001
djusted mortality after
index admission, %
1.08 1.24 .373
VAR, Endovascular aneurysm repair; SD, standard deviation.he mean number of days to the first readmission was
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January 201392 Casey et alsignificantly longer after EVAR (83 vs 57 days; P .0001),
and the mean LOS during the first readmission was signif-
icantly shorter with EVAR (2 vs 8 days; P  .0001). At 1
year, the risk-adjusted mortality rate was significantly
greater for open repair (7.79% vs 2.44%; P  .0001).
However, this significance was lost after the hospitalization
for the surgical procedure was removed from the analysis.
The adjusted mortality rate at 1 year, excluding the index
admission, was 1.08% for EVAR and 1.24% for open repair
(P  .37).
Kaplan-Meier analysis confirmed similar outcomes at 1
year for the two cohorts (Fig 2). Early in the postoperative
period, patients undergoing open repair weremore likely to
be readmitted to the hospital. This advantage, however,
was lost by 4 months after the procedure. At 1 year after
the surgical procedure, patients who had undergone EVAR
were more likely to be readmitted (P  .009).
An evaluation of the diagnoses associated with readmis-
sions between the two groups showed a greater number of
diagnoses were associated with readmissions 1 year after
open repair (Table IV). Specifically, patients who had open
repair were more likely to be readmitted 1 year with
diagnoses of failure to thrive; cardiac, pulmonary, or gas-
trointestinal complications; infection, pulmonary embo-
lism/deep venous thrombosis, and small bowel obstruc-
tion. Patients who underwent elective EVAR were more
likely to be readmitted within the first year for device-
related or aneurysm-related complications and were also
slightly more likely to be readmitted with a diagnosis of a
wound complication, although this was not statistically
Fig 2. Kaplan-Meier estimates show freedom from readmission.
At the 1-year follow-up, patients undergoing endovascular aneu-
rysm repair (EVAR) have a higher likelihood of readmission com-
pared with open repair (OPEN).significant (P  .12). aThe primary diagnoses associated with readmission
ere also evaluated to see if this was different than consid-
ring all diagnoses during readmission. Once again, the
ost common primary diagnoses for readmission for both
roups were failure to thrive, cardiac complications, and
nfection (Table V). The difference was statistically higher
n open repair than in EVAR (11.63% vs 3.97%; P 
0001); however, it was not significant in the latter two.
ther statistically significant diagnoses associated with re-
dmission after open repair included pulmonary complica-
ions (4.9%; P  .009), gastrointestinal complications
3.8%; P  .0001), pulmonary embolism/deep venous
hrombosis (0.54%; P .03), and small bowel obstruction
1.1%; P  .0001). Patients who had an EVAR were more
ikely to be readmitted with a primary diagnosis of wound
omplications (2.9%; P  .02) and device-related or aneu-
ysm-related complications, although this did not reach
tatistical significance (5.5%; P  .055).
Cox regression analysis revealed factors more likely
able IV. All diagnoses associated with readmission 1
ear after aneurysm repair
ariable
EVAR
(%)
Open
(%) P
ailure to thrive 19.7 28.4 .0001
ardiac 34.9 39.7 .0001
nfection 15.7 19.2 .0001
evice/aneurysm 12.6 10.4 .0059
ulmonary 9.8 13.3 .0001
enal 8.9 9.6 .3184
erebrovascular accident 1.8 1.8 1.0
astrointestinal 2.6 7.2 .0001
ound 5.2 4.4 .1212
mbolism 0.9 1.0 .7740
E/DVT 0.4 0.9 .006
mall bowel obstruction 0.3 1.4 .0001
VAR, Endovascular aneurysm repair; DVT, deep venous thrombosis; PE,
ulmonary embolism.
able V. Primary diagnosis listed per readmission 1
ear after aneurysm repair
ariable
EVAR
(%)
Open
(%) P
ailure to thrive 3.97 11.63 .0001
ardiac 8.61 7.81 .2406
nfection 6.84 7.09 .6863
evice/aneurysm 5.54 4.50 .055
ulmonary 3.62 4.90 .009
enal 1.45 1.22 .4336
erebrovascular accident 1.45 1.19 .3607
astrointestinal 1.20 3.85 .0001
ound 2.89 1.98 .02
mbolism 0.25 0.22 .7792
E/DVT 0.22 0.54 .03
mall bowel obstruction 0.22 1.12 .0001
VT, Deep venous thrombosis; EVAR, endovascular aneurysm repair; PE,
ulmonary embolism.ssociated with readmission 1 year for all patients in the
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Volume 57, Number 1 Casey et al 93cohort (Table VI). Open repair was a negative predictor for
readmission (hazard ratio [HR], 0.862, 95% confidence inter-
val, 0.804-0.924).Womenweremore likely to be readmitted,
as were older patients and patients withmore comorbidities as
measured by Charlson Index. Other predictors of readmis-
sion 1 year included Medicaid insurance, increased LOS
at surgery, congestive heart failure (CHF), and complicated
hypertension. PVD conferred a protective advantage
against readmission (HR, 0.675; 95% confidence interval,
0.536-0.851). Race, DM, and COPD were not associated
with an increased risk of readmission within the first year
after the procedure.
DISCUSSION
Multiple randomized and nonrandomized controlled
trials have demonstrated an early morbidity and mortality
advantage after elective EVAR compared with elective open
repair.6-8 Interestingly, when pooled trial data have been
compared for high-risk patients, this early advantage was
not confirmed.9 Similarly, most large studies demonstrated
no survival advantage when longer follow-up was per-
formed.2,6 Some doubt still exists in the literature about the
exact reasons for loss of the survival advantage with longer-
term follow-up and may simply represent the comorbid
cardiovascular factors of many patients undergoing elective
aneurysm repair, whether open or EVAR.
Our goal in this study was to use an administrative
database to identify all patients in California who under-
went elective AAA repair and track their readmissions
through the first year. Early mortality outcomes are in
agreement with other studies. In this study, operative mor-
tality was 1.4% after EVAR and 6.7% after open repair,
which was comparable to the 1.7% and 6% rates in the
Dutch Randomised Endovascular Aneurysm Management
(DREAM) trial.2 Because the patient cohorts in this cur-
rent study were not homogenous, this likely had an effect
on overall patient outcomes and is an acknowledged issue
with administrative databases.
We found in the California database that patients who
Table VI. Predictors of readmission 1 year after
aneurysm repair
Factor HR (95% CI) P
Open repair 0.862 (0.804-0.924) .0001
Female 1.091 (1.005-1.184) .0066
Age 1.012 (1.008-1.017) .0001
Charlson index
2 1.358 (0.913-2.022) .0473
3 1.656 (1.106-2.481) .0013
Medicaid 1.220 (0.986-1.508) .0159
Length of stay 1.014 (1.011-1.017) .0001
CHF 1.324 (1.205-1.455) .0001
Hypertension 1.306 (1.205-1.415) .0001
PVD 0.675 (0.536-0.851) .0009
CHF, Congestive heart failure; CI, confidence interval; HR, hazard ratio;
PVD, peripheral vascular disease.had EVARwere more likely to be older, men, and less likely ro have private insurance. However, patients undergoing
pen repair were more likely to be sicker with more comor-
idities. The mean Charlson Index value for patients with
n open repair was 1.72, which was significantly higher
han the 1.67 value for EVAR patients (P  .0001). Pa-
ients with open repair were more likely to have a history of
HF, complicated DM, and complicated hypertension.
his selection bias of offering healthier patients EVAR may
artly explain the increased early mortality after open repair
n California.
Analysis of the readmission data, the focus of this study,
ighlights some interesting factors about this cohort. First,
eadmission rates of 55.4% and 52.1%1 year after the two
rocedures seemed excessive at first glance. Although not
very one of these subsequent admissions can be directly
elated to the patients’ aneurysm repairs, it underscores that
atients with aneurysmal disease mostly have significant
omorbidities and are of the age that return to the hospital
t a surprisingly high rate in the first year after their surgery.
It is plausible that the true incidence of readmissions is
ften under-reported, albeit a number of them not neces-
arily as a direct result of the surgical procedure. A patient
ay present to another institution or even to a different
ervice within the same hospital. Often the readmission will
ot be viewed as a consequence of the initial procedure and
s unbeknownst to the original surgeon. One of the
trengths of the particular database used in this study is it
aptures readmissions within the entire state, so is much less
ikely to underestimate true readmission rates.
Obviously, when combining readmission diagnoses,
he current data suggest that a significant percentage of
eadmissions are related to the original operation. Admis-
ion diagnoses coded as primary during readmission in-
lude failure to thrive and cardiac complications and were
ignificantly higher in the open group, highlighting the
ore invasive nature and a predictably more difficult recov-
ry process. This assertion is supported by a longer LOS at
he initial hospitalization, fewer days to the first readmis-
ion, and a longer LOS at readmission.
Second, it also suggests that in California, sicker pa-
ients had an open repair, as documented by a larger
ercentage of patients who had CHF, COPD, and a higher
harlson Index score undergoing open repair over EVAR.
his clearly documents the evolution and ultimate prefer-
nce of EVAR to now replace open repair in the uncompli-
ated aneurysm patient.
Finally, given the preference toward EVAR, patients
ho are more challenging are likely undergoing open re-
air, potentially with suprarenal clamping, which is also
aking the operations longer, more challenging, and po-
entially, with worse early results. These factors may cer-
ainly then contribute to a longer and more challenging
ostoperative course, increasing early readmission rates.
That early operative outcomes favor EVAR in Califor-
ia is not a surprise. In addition to the improved survival,
VAR had a lower 30-day readmission rate, longer time to
he first readmission, and shorter hospitalization at that first
eadmission. This is a comparable result to the Veterans
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January 201394 Casey et alAdministration population, wherein a review of 45,000
patients who underwent elective AAA repair, Bush et al10
found a significantly lower 30-day mortality and complica-
tion rate after EVAR. The median LOS was shorter for
EVAR than for open repair in the intensive care unit (1 vs 4
days) and the hospital (3 vs 7 days).
What focusing on early outcomes fails to discover,
however, is the readmission rates. Despite the greater num-
ber of overall readmission diagnoses associated with open
repair early on in the initial postoperative recovery, by 4
months after surgery, there was crossover where EVAR
readmissions overtook open repair. This trend continued
and became statistically significant at 1 year. Open repair
actually conferred an advantage against readmission com-
pared with EVAR (odds ratio, 0.862) at 1 year, a seemingly
counterintuitive finding. Kaplan-Meier analysis (Fig 2)
documents this, demonstrating fairly parallel lines between
the two groups with respect to readmission rates after the
first 120 days. Furthermore, the significantly higher 1-year
mortality rate for open repair can largely be contributed to
the greater number of deaths at the surgical hospitalization.
Once this hospitalization was removed from the analysis,
the predicted 1-year mortality rate was 1.08% for EVAR
and 1.24% for open repair, which was not statistically
significant (P  .372).
When looking at readmission rates, the use of the
Healthcare Cost and Utilization Project SID allowed us to
track patients by index hospitalization as well as by all
subsequent readmissions within the first year of surgery. To
improve the precision of the causes for readmission, we
compared all diagnoses as well as only primary diagnoses.
The most common primary diagnoses associated with re-
admissions in either cohort were failure to thrive, cardiac
complications, and infection; however, at 11.63%, only
failure to thrive was significantly higher in the open group.
Cardiac complications and infection were similar between
the two groups. This was despite the significantly higher
number of patients in the open repair group who had CHF.
The significant number of readmissions associated with
primary diagnoses of cardiac complications and infection is
not surprising given the age of the population and baseline
comorbidities. Other studies have demonstrated similar
results.11-13
There were also a significant number of patients with
COPD at baseline in this study (29.2% in the EVAR and
37.7% in the open repair group). The link between tobacco
use and aneurysm formation and growth is well docu-
mented.14 Interestingly, this seemed to predict a higher
number of subsequent pulmonary readmissions in the open
repair group only, arguing that EVAR is reasonable in the
patient with significant pulmonary comorbidities.
One surprising finding is the wound complication re-
admission rate after EVAR. We anticipated that wound
issues would be greater after open repair, as has been found
in previous studies, where laparotomy-related complica-
tions as high as 23% have been reported in other surgical
cohorts,15 compared with as low as 2% after open femoral
access.16,17 However, this was not replicated in our cohort Snalysis. This suggests that focusing on lower-profile de-
ices or more percutaneous access might further improve
eadmission rates after EVAR.18 Although incisional hernia
as included in the category of wound complication read-
ission, it is probable that many of these do not develop or
re evaluated until 1 year after surgery.
Finally, focusing on predictors of readmission may help
ith system-based approaches toward improving outcomes
fter aneurysm repair. In this study, predictors of readmis-
ion within the first year for either type of repair include
emale sex (HR, 1.09), older age (HR, 1.01), and patients
ith Medicaid insurance (HR, 1.22). Not surprisingly,
atients who are sicker (Charlson Index 2 and 3) and
atients with an increased LOS during their hospitalization
ere also at a greater risk of readmission within the first
ear. These risk factors should also be incorporated into
reoperative discussions about realistic expectations about
he function and quality of life after aneurysm repair,
hether open or EVAR.
There are obvious limitations to this database analysis,
nd issues with administrative databases are acknowl-
dged and well documented in the literature. Miscoded
vents and incomplete coding are not uncommon events
uring hospitalizations and could have accounted for a
ertain amount of error in this study. Principle diagnoses
end to be accurate; however, secondary diagnoses and
omorbid diagnoses are often under-reported. Further-
ore, actual causes of readmission using a database of this
ort can be difficult to identify due to accurate reasoning by
he abstractor of the billing vs what the physician deter-
ines and can make analysis challenging. Also, the admis-
ion may or may not even be related to the actual surgery;
or example, a heart attack requiring admission 9 months
fter surgery might have happened without the open or
VAR procedure. Finally, there is no way to know the
umber of patients who were readmitted to hospitals out-
ide of California. We still believe this particular database
nalysis is useful in determining relatively accurate readmis-
ion rates and causes after aneurysm repair.
ONCLUSIONS
Total readmission rates within 1 year after elective AAA
epair are greater after EVAR compared with open repair.
easons for readmissions vary between the two cohorts.
urther prospective studies should be performed to con-
rm those patients that are at increased risk of readmission
fter elective AAA repair. In addition, systems-based anal-
sis of these causes of readmission can potentially improve
atient expectations and care after elective aneurysm repair.
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